rs1417991590
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001011658.4(TRAPPC2):c.*1288T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00010 ( 0 hom., 3 hem., cov: 19)
Exomes 𝑓: 0.0 ( 0 hom. 0 hem. )
Failed GnomAD Quality Control
Consequence
TRAPPC2
NM_001011658.4 3_prime_UTR
NM_001011658.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.546
Publications
0 publications found
Genes affected
TRAPPC2 (HGNC:23068): (trafficking protein particle complex subunit 2) The protein encoded by this gene is thought to be part of a large multi-subunit complex involved in the targeting and fusion of endoplasmic reticulum-to-Golgi transport vesicles with their acceptor compartment. In addition, the encoded protein can bind c-myc promoter-binding protein 1 and block its transcriptional repression capability. Mutations in this gene are a cause of spondyloepiphyseal dysplasia tarda (SEDT). A processed pseudogene of this gene is located on chromosome 19, and other pseudogenes are found on chromosomes 8 and Y. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2010]
TRAPPC2 Gene-Disease associations (from GenCC):
- spondyloepiphyseal dysplasia tarda, X-linkedInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- spondyloepiphyseal dysplasia tardaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BS2
High AC in GnomAd4 at 9 XL,AD gene.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001011658.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TRAPPC2 | MANE Select | c.*1288T>G | 3_prime_UTR | Exon 6 of 6 | NP_001011658.1 | P0DI81-1 | |||
| TRAPPC2 | c.*1288T>G | 3_prime_UTR | Exon 6 of 6 | NP_001122307.2 | P0DI81-3 | ||||
| TRAPPC2 | c.*1288T>G | 3_prime_UTR | Exon 5 of 5 | NP_055378.1 | P0DI81-1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TRAPPC2 | TSL:1 MANE Select | c.*1288T>G | 3_prime_UTR | Exon 6 of 6 | ENSP00000369953.1 | P0DI81-1 | |||
| TRAPPC2 | c.*1288T>G | 3_prime_UTR | Exon 6 of 6 | ENSP00000507474.1 | P0DI81-3 | ||||
| TRAPPC2 | TSL:1 | c.*1288T>G | 3_prime_UTR | Exon 5 of 5 | ENSP00000352708.5 | P0DI81-1 |
Frequencies
GnomAD3 genomes AF: 0.0000997 AC: 9AN: 90264Hom.: 0 Cov.: 19 show subpopulations
GnomAD3 genomes
AF:
AC:
9
AN:
90264
Hom.:
Cov.:
19
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 198Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 88
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
198
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
88
African (AFR)
AF:
AC:
0
AN:
4
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
1
East Asian (EAS)
AF:
AC:
0
AN:
8
South Asian (SAS)
AF:
AC:
0
AN:
5
European-Finnish (FIN)
AF:
AC:
0
AN:
3
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
0
AN:
170
Other (OTH)
AF:
AC:
0
AN:
7
GnomAD4 genome AF: 0.0000997 AC: 9AN: 90296Hom.: 0 Cov.: 19 AF XY: 0.000133 AC XY: 3AN XY: 22510 show subpopulations
GnomAD4 genome
AF:
AC:
9
AN:
90296
Hom.:
Cov.:
19
AF XY:
AC XY:
3
AN XY:
22510
show subpopulations
African (AFR)
AF:
AC:
7
AN:
23680
American (AMR)
AF:
AC:
1
AN:
7341
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2358
East Asian (EAS)
AF:
AC:
0
AN:
2739
South Asian (SAS)
AF:
AC:
0
AN:
1826
European-Finnish (FIN)
AF:
AC:
0
AN:
4046
Middle Eastern (MID)
AF:
AC:
0
AN:
143
European-Non Finnish (NFE)
AF:
AC:
1
AN:
46385
Other (OTH)
AF:
AC:
0
AN:
1174
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions
View on ClinVar Significance:Uncertain significance
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
1
-
Spondyloepiphyseal dysplasia tarda (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.